Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Discover the full record of transactions filed by Causey Christopher, Director. Officer active across 1 company, notably UNITED THERAPEUTICS Corp. In total, 36 disclosures have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €2.1m. History available since 26 May 2021. The latest transaction was filed on 30 March 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Causey Christopher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5000 títulos@ 236,79 US$21.3% de su flujoCommon StockSEC:0001415889-22-007024:1
25 de 36 declaraciones
About Causey Christopher
CAUSEY CHRISTOPHER is a Director at UNITED THERAPEUTICS Corp (XNAS). He has 36 filings, and across the sampled recent filings the sell amount is EUR 2074069, with filings dated from 2016-01-08 to 2026-03-31. The modal transaction nature is Levée d'options.